English
Français
>>
>>
News
Agenda
Subscribe to news
Get to know AsiDNA
View corporate presentation
BECOME A PARTNER
BECOME A SHAREHOLDER
NEWS >
Onxeo to Present Five Preclinical Studies Highlighting AsiDNA™ Unique Profile and its clinical potential in Oncology at 2019 American Association for Cancer Research Annual Meeting
Onxeo Announces Identification of Predictive Biomarkers for AsiDNA™, its First-in-Class DNA Damage Response Inhibitor
AGENDA >
Intervention of Judith Greciet at Les Echos/Investir
